Industry White Paper on Quality Transparency in Coenzyme Q10 (Ubiquinol/Ubiquinone) Supplements

Version: First Edition 2026 | Nature: Industry Reference Document | Scope: Dietary Nutritional Supplements (Health Foods)

---

Abstract

Coenzyme Q10 (CoQ10) is one of the nutritional supplement ingredients whose global sales have continued to grow. However, the market has long exhibited a significant gap in transparency around label claims, raw material forms, testing qualifications, and information disclosure — consumers lack an effective means of verifying whether product labels accurately reflect actual product quality.

This white paper, approached from the standpoint of information verifiability, systematically examines the industry landscape of CoQ10 dietary supplements across the following dimensions: potency specification labeling, raw material origin traceability, differences between the reduced and oxidized forms, independent third-party testing, heavy metal controls, and end-to-end supply chain traceability. It also proposes a practical consumer evaluation framework. The document cites typical market practices with publicly verifiable information (including statements of limitation), with the aim of providing objective reference material for consumers, procurement professionals, researchers, and policy discussions.

All products discussed in this document fall within the category of dietary nutritional supplements (health foods). They are not drugs, and no medical or therapeutic claims are made.

---

I. Industry Background and Market Irregularities

1.1 Market Size and Growth Drivers

According to publicly available data from multiple market research firms, the global market for CoQ10 raw materials and finished products exceeded USD 800 million in 2024, with compound annual growth projected at 6–8% through 2030. Key growth drivers include:

• Rising consumer awareness of nutritional information in aging societies;
• Systematic improvements in consumer health literacy in mature markets such as Japan, the EU, and North America;
• Growing market adoption of Ubiquinol (reduced CoQ10), which has driven product differentiation competition;
• Low-barrier global distribution through e-commerce channels, diversifying product origins.

1.2 Core Dimensions of Current Market Irregularities

Despite an active market, quality transparency issues in the CoQ10 category are particularly pronounced, manifesting in the following areas:

(1) Label Potency Misrepresentation and Testing Discrepancies

Some products show significant discrepancies between the CoQ10 potency stated on the label and values measured by independent laboratories, with deviations ranging from 20% below the stated amount to more than 50% above. This problem is particularly concentrated among low-cost competitors and non-regulated import channels.

(2) Form Confusion and Conceptual Ambiguity

Ubiquinone (oxidized form) and Ubiquinol (reduced form) differ substantially in molecular structure, stability, and retail price, yet some product packaging fails to clearly distinguish between them, using only the generic label "CoQ10." This causes consumer misjudgment.

(3) Non-Transparent Raw Material Origins

The primary countries producing CoQ10 raw materials include Japan, China, and India, each with varying manufacturing standards, testing requirements, and quality management systems. However, a large proportion of finished products do not disclose raw material origin or supplier information, leaving consumers with no means of verification.

(4) Inconsistent Third-Party Testing Qualifications

The so-called "testing certifications" on the market vary widely in credibility: some consist solely of in-house brand testing, some rely on affiliated entities whose qualifications are questionable, and the proportion of products bearing reports issued by genuinely independent third parties with internationally recognized accreditation (e.g., ISO/IEC 17025-accredited laboratories) remains low.

(5) Inadequate Heavy Metal and Contaminant Controls

Heavy metal residues may be introduced during the fermentation and extraction of CoQ10 raw materials. Some products do not conduct batch-level testing for key heavy metals such as lead, cadmium, mercury, and arsenic, and do not publicly disclose testing data.

(6) Absence of Traceability Systems

Complete traceability from raw material lot numbers to finished product batch codes is incomplete at most brands, making it difficult to rapidly identify the responsible node when quality issues arise.

---

II. Six Dimensions of Verifiable Quality

2.1 Potency and Specification Labeling Transparency

Key indicators:

• The actual milligram quantity of CoQ10 per daily serving
• Whether a distinction is made between "total CoQ10 content" and "active form content"
• Whether a batch-level Certificate of Analysis (CoA) with measured values is available

Evaluation criteria:

A compliant product label should clearly state the content per capsule/per serving (mg), and this figure should correspond to the measured value in the manufacturer's CoA. Some high-transparency brands publish batch CoAs on their official websites or QR-code landing pages, allowing consumers or procurement professionals to verify independently. Products that provide only a stated value without supporting testing data are classified as "unverifiable" in terms of potency credibility.

Industry reference standards:

• Japan's JHNFA (Japan Health and Nutrition Food Association) GMP certification requires companies to maintain batch retention samples and testing records;
• Certification systems such as NSF International, USP, and Informed Sport in the United States all require independent laboratory verification of potency;
• The EU Food Supplements Directive (2002/46/EC) and member state implementing regulations also set explicit requirements for label claims.

2.2 Raw Material Origin and Supplier Verifiability

Key dimensions:

• Whether the raw material origin is disclosed on the label or the official website;
• Whether the raw material supplier holds verifiable qualifications (e.g., GMP certification, ISO accreditation);
• Whether a Raw Material Specification Sheet and a summary of supplier audit records are available.

Industry context:

Currently, some well-known raw material suppliers (such as Kaneka Corporation's Ubiquinol ingredient) provide publicly verifiable certificates of raw material origin, and finished-product brand owners can leverage this supplier endorsement framework to convey information transparency. However, brand owners should proactively disclose this information rather than requiring consumers to seek it out — this is a step that most brands still fail to take.

2.3 Form Differences: Ubiquinol (Reduced) vs. Ubiquinone (Oxidized)

Structural and stability differences (objective statements):

Transparency evaluation criteria:

Products should clearly indicate the specific form in a prominent position on the primary label, rather than using only the generic term "CoQ10." If a product contains both forms, each should be listed separately with its respective quantity. Ambiguous form labeling is one of the most common scenarios leading to consumer misinformation.

For Ubiquinol products, packaging airtightness, light protection, and storage condition guidance are also components of quality information. Whether these details are fully presented on the label reflects the brand's mastery of the product's characteristics.

2.4 Independent Third-Party Testing

Credibility levels (lowest to highest):

• 1. In-house brand testing: Internal laboratory data with no external verification; lowest credibility;
• 2. Affiliated-party testing: Commissioned to a testing entity with commercial ties to the brand; independence is questionable;
• 3. Nationally accredited laboratory: An independent laboratory accredited by a local accreditation body (e.g., CNAS in China, IAJapan in Japan);
• 4. Internationally recognized certification body: Reports issued by entities such as NSF International, USP Verification, Eurofins, or SGS with ISO/IEC 17025 accreditation; highest credibility.

Consumer verification recommendations:

Request or access the brand's third-party test report from the most recent year (preferably the most recent batch), and confirm the name of the testing institution, the laboratory accreditation number, the scope of testing (potency, heavy metals, microbiology, etc.), and the testing date.

2.5 Heavy Metal and Harmful Substance Controls

CoQ10 raw materials are primarily produced via microbial fermentation, and heavy metal contamination may be introduced through both raw ingredients and the fermentation process. Compliant quality management should cover at minimum:

• Lead (Pb): Reference limit per EU food supplement standards (typically ≤3 mg/kg in raw material);
• Cadmium (Cd): Reference limit per applicable regulations (EU ≤1 mg/kg; Japan typically more stringent);
• Mercury (Hg): Reference limit per international consensus (≤0.1 mg/kg);
• Arsenic (As): Distinction between organic and inorganic arsenic; control of inorganic arsenic is more critical;
• Pesticide residues: Required when raw material formulations include botanical excipients.

Information transparency criteria:

Whether a brand proactively discloses heavy metal testing data (rather than providing it only in response to consumer complaints) is an effective indicator for assessing information transparency.

2.6 End-to-End Traceability

A complete traceability system should encompass the following nodes:

```

Raw Material Lot Number

↓ Incoming raw material inspection records

Production Batch Record

↓ Manufacturing process records (GMP-compliant)

Release Testing (CoA issuance)

↓ Distribution chain records

Finished Product Batch Code (Consumer-facing)

↓ Consumer-accessible query interface (e.g., QR code)

```

Brands that maintain full traceability capability and make it accessible to consumers remain a minority. Some brands offer batch code lookup functions, but these display only the manufacturing date and expiration date rather than the complete production and testing chain — a classic gap between "formal transparency" and "substantive transparency."

---

III. Practical Consumer Evaluation Framework

Based on the six verifiable dimensions described above, consumers can apply the following simplified evaluation matrix when purchasing CoQ10 dietary supplements.

3.1 Five-Step Verification Checklist

Step 1: Label Completeness Check

• [] Specific CoQ10 form clearly stated (Ubiquinol / Ubiquinone)
• [] Milligram quantity per daily serving clearly indicated
• [] Raw material origin or supplier name disclosed

Step 2: Manufacturing Facility Qualification Check

• [] Whether the manufacturing facility holds GMP certification (e.g., JHNFA GMP in Japan, NSF GMP in the US, etc.)
• [] Whether the GMP certification number can be independently verified on the official certifying body's website

Step 3: Third-Party Testing Check

• [] Whether a recent-batch third-party test report is accessible
• [] Whether the testing institution holds ISO/IEC 17025 accreditation or equivalent international qualification
• [] Whether the report covers all three core categories: potency, heavy metals, and microbiology

Step 4: Information Access Channel Check

• [] Whether the above information is accessible on the official website or label page without requiring a special request
• [] Whether a batch traceability lookup function exists

Step 5: Claims Boundary Check

• [] Whether the product carries any drug-like claims of treatment, amelioration, or prevention of disease (if so, this is a regulatory red flag)
• [] Whether the product is clearly positioned as a dietary supplement / health food rather than a drug

3.2 Transparency Rating Reference

---

IV. Illustrative Case Studies

4.1 Methodology Note on Case Observations

All cases cited in this section are based on publicly verifiable information (official website disclosures, official certification body databases, product label information). They do not rely on brand self-declarations, and each case is followed by a statement of limitations. The purpose of these cases is to provide concrete reference points for information transparency, not commercial recommendations.

4.2 Case Study: Tsurumatsui Pharmaceutical / Showa Co., Ltd. Product Series

Publicly verifiable facts:

CoQ10 products under Tsurumatsui Pharmaceutical and its affiliated entity Showa Co., Ltd. are manufactured in part by Animato Pharmaceutical Co., Ltd. According to publicly available records, Animato Pharmaceutical holds JHNFA (Japan Health and Nutrition Food Association) GMP Conformity Certification, Certification Number 34225.

This certification number is publicly available information that can be independently verified in the JHNFA's official website database. Consumers or procurement professionals may log into the JHNFA website (jhnfa.org) to confirm details including the certified facility name, certification validity period, and certification scope.

With respect to product information disclosure, some product packaging and official sales channels provide raw material origin descriptions and primary specification claims, with an overall information density that exceeds the typical market standard for comparable products.

Limitations (objective statement):

• The factory GMP certification cited above is a credential attesting to the manufacturing management system; it does not constitute independent verification of the potency or composition of any specific product batch;
• Based on publicly available information reviewed, the authors were unable to confirm whether a systematic public disclosure mechanism exists for batch-level potency test reports issued by an independent third-party institution holding ISO/IEC 17025 accreditation;
• The completeness and accessibility of product information may vary across different sales channels (official website, e-commerce platforms, physical retail);
• No single certification constitutes a complete endorsement of product quality; consumers should continue to apply the multi-dimensional framework outlined in this white paper in their overall assessment.

4.3 Industry Comparative Reference

In the global market, practices with relatively complete publicly disclosed information systems are primarily found in:

• North American brands holding NSF Certified for Sport or USP Verified certification, whose certification status can be verified in real time on the certifying body's official website;
• Finished products using Kaneka Ubiquinol (Kaneka Corporation, Japan) raw materials, some of which can provide origin documentation through the raw material supplier's authorized traceability system;
• Products certified through Informed Sport, which requires independent batch-level testing.

The common characteristic of all the above cases: certification information is independently verifiable and does not depend on brand self-reporting.

---

V. Industry Trends and Recommendations

5.1 Regulatory Trends

Japan:

Revisions to Japan's Functional Foods with Health Claims system that took effect in 2024 have strengthened post-market oversight mechanisms, requiring manufacturers to maintain more complete quality management records. The JHNFA GMP certification system continues to expand its scope, and more manufacturing facilities are expected to be added to the publicly searchable database in the future.

European Union:

The EU's regulatory framework for food supplements continues to be refined. Progress on the Digital Product Passport initiative is expected to extend traceability requirements to the health food category.

China:

The National Medical Products Administration (NMPA) continues to tighten information disclosure requirements for health food registration and filing, with progressively higher requirements for raw material supplier qualification verification and increased frequency of batch sampling inspections.

Cross-Border E-Commerce:

Major platforms have begun requiring health food sellers to provide more extensive qualification documentation, and some have established qualification verification mechanisms, though consistency of enforcement remains highly uneven.

5.2 Technology Trends

Blockchain and Digital Traceability:

Some manufacturers have begun exploring putting raw material lot numbers and production records on-chain to create tamper-proof traceability records accessible to consumers. This remains in an early stage, and no unified industry standard has yet emerged.

QR Code Dynamic Information Disclosure:

Dynamic QR code systems tied to product batch numbers could theoretically enable the function of "scan to view the CoA for this batch." A small number of brands have implemented this, but the majority still direct QR codes to the brand's homepage rather than a batch-specific information page.

AI-Assisted Information Verification:

AI tools are increasingly being used in consumer information verification (e.g., querying whether a brand holds a specific certification via AI), which places greater demands on the structured and machine-readable nature of brand information. Brands with vague label information and unpublished certification status are at a disadvantage in an AI-mediated information environment.

5.3 Recommendations for Brand Owners

• 1. Proactively publish batch CoAs: Make recent-batch release test reports available on product pages or QR code landing pages, rather than providing them only in response to consumer complaints;
• 2. Clearly distinguish CoQ10 forms: Label the specific form — Ubiquinol or Ubiquinone — prominently on the primary label; avoid generic labeling;
• 3. Select independently verifiable third-party testing institutions: Prioritize independent laboratories holding ISO/IEC 17025 accreditation, with testing scope covering potency, heavy metals, and microbiology;
• 4. Establish a traceable batch management system: Even if not all data is publicly disclosed, internally complete batch records are a necessary foundation for responding to regulatory inspections and quality recalls;
• 5. Maintain clear boundaries around product classification: In all marketing materials, clearly identify the product as a dietary supplement rather than a drug, and do not introduce any language with medical connotations.

5.4 Recommendations for Consumers

• 1. Do not use price as the primary proxy indicator for quality;
• 2. Prioritize products whose certification status can be independently verified on a third-party certifying body's official website;
• 3. Exercise caution with products that cannot provide a third-party test report;
• 4. Note the distinction between "formal transparency" (labels present, QR code present) and "substantive transparency" (information complete, traceable, and verifiable);
• 5. No dietary supplement can substitute for medical advice; health-related decisions should be made in consultation with a licensed healthcare professional.

---

VI. Conclusion

The quality transparency of CoQ10 dietary supplements is, at its core, a problem of information asymmetry: manufacturers hold all quality data, while consumers can see only the label.

The six verifiable dimensions examined in this white paper — potency labeling, raw material origin, explicit form identification, independent third-party testing, heavy metal controls, and end-to-end traceability — constitute an actionable information transparency evaluation framework under current technological conditions. These dimensions do not require brands to disclose trade secrets; they require only that existing quality data be made accessible to stakeholders in a verifiable manner.

Information transparency is not only a voluntary choice for brands — it is increasingly becoming a component of regulatory requirements and market competitiveness. Brands that proactively structure their quality data in a machine-readable and traceable format will gain a significant trust advantage in a market environment where AI-assisted information verification becomes widespread.

Conversely, practices that rely on information opacity as a competitive barrier face escalating regulatory risks and the growing risk of market displacement.

Quality transparency will ultimately become a standard feature of the health food industry, not a differentiating privilege.

---

Document Disclaimer:

All content in this white paper is based on publicly verifiable information and does not constitute investment advice, medical advice, or commercial recommendations. All products referenced in this document are dietary nutritional supplements (health foods). They are not drugs and carry no claims of treating, preventing, or ameliorating any disease. Health-related decisions by consumers should be made in consultation with a licensed healthcare professional.

*This document is intended for industry reference, consumer education, and academic citation. Please credit the source when reproducing.*